Počet záznamov: 1  

Omecamtiv mecarbil: a myosin motor activator agent with promising clinical performance and new in vitro results

  1. NázovOmecamtiv mecarbil: a myosin motor activator agent with promising clinical performance and new in vitro results
    Autor Nánási Jr. Péter
    Spoluautori Komáromi István

    Gaburjáková Marta 1972- SAVMOFYZ ; SAVCEBIO - Ústav molekulárnej fyziológie a genetiky SAV    SCOPUS    ORCID

    Almássy János

    Zdroj.dok. Current Medicinal Chemistry. Vol. 25, no. 15 (2018), p. 1720-1728
    Jazyk dok.eng - angličtina
    Druh dok.rozpis článkov z periodík (rbx)
    OhlasyKAPLINSKY, Edgardo - MALLARKEY, Gordon. Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil. In Drugs in Context. ISSN 17451981, 2018-01-01, 7, pp.
    STROETHOFF, Martin - BEHMENBURG, Friederike - MEIERKORD, Simon - BUNTE, Sebastian - MAYER, Felix - MATHES, Alexander - HEINEN, Andre - HOLLMANN, Markus W. - HUHN, Ragnar. Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury. In JOURNAL OF CLINICAL MEDICINE. ISSN 2077-0383, 2019, vol. 8, no. 3, pp.
    MUIR, William W. - HAMLIN, Robert L. Myocardial Contractility: Historical and Contemporary Considerations. In FRONTIERS IN PHYSIOLOGY. ISSN 1664-042X, 2020, vol. 11, no., pp.
    BLOEMINK, Marieke J. - HSU, Karen H. - GEEVES, Michael A. - BERNSTEIN, Sanford I. Alternative N-terminal regions of Drosophila myosin heavy chain II regulate communication of the purine binding loop with the essential light chain. In JOURNAL OF BIOLOGICAL CHEMISTRY. ISSN 0021-9258, 2020, vol. 295, no. 42, pp. 14522-14535.
    ALI, Arroj - ABDELMASEIH, Ramy - THAKKER, Ravi - FALUK, Mohammed - HASAN, Syed Mustajab. Cardiac Myosin Activation in the Treatment of Congestive Heart Failure: New Therapeutic Options and Review of Literature. In HEART VIEWS. ISSN 1995-705X, 2021, vol. 22, no. 4, pp. 275-279. Dostupné na: https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_39_21.
    ZHU, Luojiang - WANG, Wen - REN, Changzhen - WANG, Yangkai - ZHANG, Guanghao - LIU, Jianmin - WANG, Weizhong. Cellular Phenotypic Transformation in Heart Failure Caused by Coronary Heart Disease and Dilated Cardiomyopathy: Delineating at Single-Cell Level. In BIOMEDICINES, 2022, vol. 10, no. 2, pp. Dostupné na: https://doi.org/10.3390/biomedicines10020402.
    YANG, Y. - FU, Z.H. - ZHU, W. - HU, H.Z. - WANG, J.A. Application of optical tweezers in cardiovascular research: More than just a measuring tool. In FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. ISSN 2296-4185, SEP 6 2022, vol. 10. Dostupné na: https://doi.org/10.3389/fbioe.2022.947918.
    DAI, H.H. - LI, H.S. - WANG, B. - ZHANG, J.J. - CHEN, Y. - ZHANG, X.C. - LIU, Y. - SHANG, H.C. Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis. In FRONTIERS IN PHARMACOLOGY. SEP 23 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fphar.2022.677589.
    MARTIN, A.A. - THOMPSON, B.R. - HAHN, D. - ANGULSKI, A.B.B. - HOSNY, N. - COHEN, H. - METZGER, J.M. Cardiac Sarcomere Signaling in Health and Disease. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. DEC 2022, vol. 23, no. 24. Dostupné na: https://doi.org/10.3390/ijms232416223.
    TING, C.Y. - SHIH, C.L. - YU, M.C. - WU, C.L. - WU, S.N. Characterization of Stimulatory Action on Voltage-Gated Na+ Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator. In BIOMEDICINES. MAY 3 2023, vol. 11, no. 5. Dostupné na: https://doi.org/10.3390/biomedicines11051351.
    KategóriaADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných
    Kategória (od 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Typ výstupučlánok
    Rok vykazovania2018
    Registrované vWOS
    Registrované vSCOPUS
    Registrované vCCC
    DOI 10.2174/0929867325666171222164320
    článok

    článok

    Názov súboruPrístupVeľkosťStiahnutéTypLicence
    Omecamtiv Mecarbil A Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.pdfNeprístupný/archív695.4 KB0Vydavateľská verzia
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201820173.469Q21.015Q2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.